Markets
Recent
ALNY Watch
Alnylam Pharmaceuticals
$274.21
$-2.43 -0.88%
1 Min 5 Min 15 Min Hourly Daily
Assets Gross Profit Revenue Earnings
Chart Sentiment News Fundamentals About
Goldman
@goldman_sa...
72.2% Winrate 1.2% Avg Gain -1.2% S&P Beat
Bought ALNY Shares
33d ago • Swung • Bullish
down -0.29% At 275.0, Exited 274.2
Investing in ALNY seems promising due to its successful phase III study for Anvuttra in treating ATTR amyloidosis with cardiomyopathy, coupled with be... Read More
Exited 26d ago
0 0